Inborn Errors of Bile Acid Synthesis
📧 Sign up to get email alerts when something new happens for Inborn Errors of Bile Acid Synthesis.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2020-07-15EMA Withdrawn: Kolbam (cholic acid) — Retrophin Europe Ltd
Kolbam (cholic acid) has been withdrawn from the market in the EU by Retrophin Europe Ltd according to EMA records.
-
CLINICAL_TRIALS trial_result · 2016-12-09Clinical Trial Update: Efficacy of To Be Marketed (TBM) Cholic Acid Capsules Used to Treat Children With Inborn Errors of Bile Acid Synthesis [Phase 3]
Phase 3 trial update of TBM cholic acid capsules for children with inborn errors of bile acid synthesis has completed with posted results.